Virtual Wholesaler/Broker (VW)
Virtual manufacturers participate in the sales and marketing of prescription drugs under their own label.
Pharma Solutions has assisted virtual manufacturers with business strategy and consulting, DEA compliance, FDA registration (labeler code & license reporting), operational audits, outsourcing a quality management system (QMS), state licensing (assessing, obtaining new licenses, and maintaining license renewals), and NABP Drug Distributor Accreditation.
Our clients range from businesses with over $2B in annual revenue to start-up companies.
Our Solutions
NavigateSOM
Our Suspicious Order Monitoring (SOM) software helps pharmaceutical manufacturers and distributors make sure that they follow DEA requirements. Federal and state agencies are increasing investigation into the players of the pharmaceutical supply chain.
LighthouseAI
LighthouseAI leverages AI-technology to perform instant compliance assessments across all state and federal jurisdictions, identifying requirements specific to your facility, then automating regulatory surveillance for ongoing protection.
State Licensing
Keeping track of each state’s licensing requirements and processes can become an expensive and lengthy process. Let our expert consultants manage your state licensing process from start to finish.
NABP Drug Distributor Accreditation
Looking to earn NABP Drug Distributor Accreditation (formerly VAWD® Accreditation) for your business but not sure where to turn? Let us guide you through the accreditation process.
Pharmacy Consulting
When you choose Pharma Solutions for pharmacy consulting, your unique business requirements are in capable hands. As leading industry experts, we’ve got you covered with new pharmacy startup...
We’d like to hear from you
Recent Articles
FDA Extends Enforcement Deadline for Drug Supply Chain Security Act (DSCSA) Requirements
A Comprehensive Guide to Pharmaceutical State Licensing Renewals
Kentucky Has Filed Amendments to Regulations and/or New Regulations
New FDA Clarification Allows Wholesale by 503B Facilities to 503A Pharmacies
Navigating the Prescription Drug Reform Act: A New Landscape for Drug Manufacturers in Florida
Short-Dated Drug Return Scheme Becomes Short-Dated
Alabama’s New Rule Has Massive DSCSA Implications on State Regulations
FDA – OA REMS Announcement Concerning requirements to Manufacturers of Opioids
Oklahoma Pharmacy Board Unanimously Approves New Rules for Shipping Mail-Order Medications
